FDAnews Device Daily Bulletin
Jan. 27, 2005 | Vol. 2 No. 19
Genetronics Biomedical, a late-stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, has acquired Oslo-based Inovio.
Insulin pump manufacturer Animas has launched its newest insulin pump, the Animas IR 1250 in the first half of February 2005.
Biolase Technology has completed the acquisition of the intellectual property portfolio of Diodem.
Rocky Mountain Biosystems (RMBI), a Denver-area biotechnology company, has successfully completed Phase I of an NIH Small Business Innovation Research grant (SBIR).
Hindustan Syringe and Medical Devices (HMD) said it received the World Health Organization's approval for its auto disable (AD) syringe under the latter's new as well as old product assessment system.
Novo Nordisk has announced that Norditropin NordiFlex, the prefilled, multidose, liquid growth hormone in a disposable pen, is now available in the U.S. for the long-term treatment of children with growth failure due to inadequate secretion of endogenous growth hormone and adults with growth hormone deficiency.
A breakthrough system featuring synchronized hearing instruments will offer improved hearing for millions of Britons who suffer from hearing loss in both ears.
Laserscope, a pioneer in the development and commercialization of medical lasers and advanced fiber-optic devices, has signed an exclusive three-year agreement with MD International for distribution of the company's proprietary GreenLight PVP (Photoselective Vaporization of the Prostate) laser system, PVP disposable fiber optics and full aesthetic laser system line.
Masimo, the inventor of Read-Through Motion and Low Perfusion Pulse Oximetry, has announced the expansion of Masimo's sensor offering with the introduction of LNCS and LNOPv sensor series.
Spectral Diagnostics has announced the first shipment of its new i-Lynx connectivity solution.
MedCap has signed distributorship agreements for the AccuScan test kits with three established medical products supply companies in Southeast Asia.
Regeneration Technologies (RTI), the Florida-based processor of orthopedic, cardiovascular and other allograft implants, has signed a new five-year agreement with Southeast Tissue Alliance (SETA) for the recovery of human donated tissue.
Filtration and separation company Pall made another acquisition in the chromatography sector with the purchase of Euroflow for an undisclosed amount.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.